Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia

OBJECTIVE: This study sought to examine the effect of ziprasidone on olanzapine or clozapine associated medical morbidity such as insulin resistance, diabetes mellitus and impaired fasting glucose, obesity and hyperlipidemia in patients with schizophrenia or schizoaffective disorder. METHOD: This wa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hum Psychopharmacol
Autori principali: Henderson, David C., Fan, Xiaoduo, Copeland, Paul M., Sharma, Bikash, Borba, Christina P., Forstbauer, Sharon I., Miley, Kate, Boxill, Ryan, Freudenreich, Oliver, Cather, Corey, Evins, A. Eden, Goff, Donald C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4327763/
https://ncbi.nlm.nih.gov/pubmed/19283774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hup.1012
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi